Inhibidores macrocíclicos y bicíclicos de virus de hepatitis C

Un compuesto seleccionado del grupo que consiste en:**Fórmula** y o una sal farmacéuticamente aceptable del mismo. or pharmaceutically acceptable salts thereof, wherein the various substituents are defined herein, methods of using said compounds, and pharmaceutical compositions containing said compo...

Full description

Saved in:
Bibliographic Details
Main Authors VIVIAN, Randall W, LINK, John O, STEVENS, Kirk L, SCHRIER, Adam J, KARKI, Kapil K, PYUN, Hyung-Jung, TAYLOR, James G, ZIPFEL, Sheila, BJORNSON, Kyla, ZABLOCKI, Jeff
Format Patent
LanguageSpanish
Published 18.12.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Un compuesto seleccionado del grupo que consiste en:**Fórmula** y o una sal farmacéuticamente aceptable del mismo. or pharmaceutically acceptable salts thereof, wherein the various substituents are defined herein, methods of using said compounds, and pharmaceutical compositions containing said compounds.
AbstractList Un compuesto seleccionado del grupo que consiste en:**Fórmula** y o una sal farmacéuticamente aceptable del mismo. or pharmaceutically acceptable salts thereof, wherein the various substituents are defined herein, methods of using said compounds, and pharmaceutical compositions containing said compounds.
Author VIVIAN, Randall W
BJORNSON, Kyla
LINK, John O
PYUN, Hyung-Jung
SCHRIER, Adam J
TAYLOR, James G
ZIPFEL, Sheila
ZABLOCKI, Jeff
KARKI, Kapil K
STEVENS, Kirk L
Author_xml – fullname: VIVIAN, Randall W
– fullname: LINK, John O
– fullname: STEVENS, Kirk L
– fullname: SCHRIER, Adam J
– fullname: KARKI, Kapil K
– fullname: PYUN, Hyung-Jung
– fullname: TAYLOR, James G
– fullname: ZIPFEL, Sheila
– fullname: BJORNSON, Kyla
– fullname: ZABLOCKI, Jeff
BookMark eNrjYmDJy89L5WRw8MzLyEzKTMkvSi1WyE1MLspPPrw2OSczOb9YoVIhKRPBS0lVKMssKgUzMlILEksySzKLFZx5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8a7CRubGpsalpSIixMTFqAIYvNKI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ES2735355TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_ES2735355TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 14:55:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ES2735355TT33
Notes Application Number: ES20140723582T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191218&DB=EPODOC&CC=ES&NR=2735355T3
ParticipantIDs epo_espacenet_ES2735355TT3
PublicationCentury 2000
PublicationDate 20191218
PublicationDateYYYYMMDD 2019-12-18
PublicationDate_xml – month: 12
  year: 2019
  text: 20191218
  day: 18
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Gilead Sciences, Inc
RelatedCompanies_xml – name: Gilead Sciences, Inc
Score 3.0945761
Snippet Un compuesto seleccionado del grupo que consiste en:**Fórmula** y o una sal farmacéuticamente aceptable del mismo. or pharmaceutically acceptable salts...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Inhibidores macrocíclicos y bicíclicos de virus de hepatitis C
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191218&DB=EPODOC&locale=&CC=ES&NR=2735355T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUkFtsItDVN1Tc0tE3VNDNPMdZMSjRJ1gU1x42QD05TU1ETQOKSvn5lHqIlXhGkEE0MmbC8M-JzQcvDhiMAclQzM7yXg8roAMYjlAl5bWayflAkUyrd3C7F1UYP2joG2AqssNRcnW9cAfxd_ZzVnZ1tgo8ovyBZYS5sCq9YQY2YGVmAr2hyUGVzDnECbUgqQaxQ3QQa2AKBheSVCDEypxcIMnM6wi9eEGTh8ofPdQCY06xWLMDh45mWAdsrlA_vHCrmJwPIz-fDaZKBr84sVKhWSMhG8lFSFssyiUjAjIxW0Yroks1jBWZRB0c01xNlDF-iUeLi3412DYY4OMTYWY2DJy89LlWBQSE01SUqyTE0BduyAXRnj5CSDJCOzlLQkQ9Am1zRDE0kGKdzmSOGTlGbgAgUhaLGGoYUMA0tJUWmqLLDKLUmSAwcWAN1JiA0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NToNAEJ7Uaqw3rRqtf5gYbsRSoMiBaMpPqBbaKJreGhaWlIPQFKrxoXwKX8xZAtaL3mZ3k93ZTWa-md2ZWYArmaIVrolUUFQtEGQxVgUS9AIBTXEp7CoRpQG7h3S9vvMs30-VaQOSOhemrBP6XhZHRIkKUd6LUl8v1pdYZhlbmV-TBLuyW9vXTb7yjnFVhCzeHOjWZGyODd4wdDSqvEcdUVpBaPWlDdhEC1tlwmC9DFhSyuI3oti7sDXBydJiDxo0b0PLqD9ea8O2W713I1mJXr4Pd8N0zjLlMvSPudcA9Wf49Rkit1nOfXAkWbciyr0ly1VJzCmLmC6SnDMO4NK2fMMRkJXZz7Zn1lPNtC9Jh9BMs5QeAUepTIhGI3Ts0JWRQtIlvX4UE5ElucaifAydv-fp_Dd4AS3Hd0ez0dB7OIEddpwscEO8OYVmsVzRM4TfgpyXB_cNahGLAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Inhibidores+macroc%C3%ADclicos+y+bic%C3%ADclicos+de+virus+de+hepatitis+C&rft.inventor=VIVIAN%2C+Randall+W&rft.inventor=LINK%2C+John+O&rft.inventor=STEVENS%2C+Kirk+L&rft.inventor=SCHRIER%2C+Adam+J&rft.inventor=KARKI%2C+Kapil+K&rft.inventor=PYUN%2C+Hyung-Jung&rft.inventor=TAYLOR%2C+James+G&rft.inventor=ZIPFEL%2C+Sheila&rft.inventor=BJORNSON%2C+Kyla&rft.inventor=ZABLOCKI%2C+Jeff&rft.date=2019-12-18&rft.externalDBID=T3&rft.externalDocID=ES2735355TT3